Biotechnology company
Issues related to COVID-19 research and development, vaccine distribution and manufacturing; Issues related to Oncology Next Generation COVID-19 vaccines; Medicare Part B and HPV; Orphan Drug Act of 1983 Orphan Drug Tax Credit - The Build Back Better Act, H.R. 5673; Accelerated Approval Integrity Act of 2022, H.R. 6963; Prescription Drug User Fee Act (PDUFA); Medical Device User Fees Amendments (MDUFA IV); Prevent Pandemics Act, S. 3799; Cures 2.0, H.R. 6000; Issues related to BARDA/ASPR and manufacturing of COVID-19 vaccines and therapies TRIPS Waiver for COVID-19 vaccines and therapies; Outreach to Colombian Congressional Caucus on COVID-19 COVID-19 Supplemental Appropriations Act of 2022, H.R. 7007, AG/FDA FY2023 appropriations, State, Foreign Ops FY2023 appropriations; LHHS FY2023 appropriations
HCR - Health Issues BUD - Budget/Appropriations
25 - Defense, Dept of (DOD) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 39 - State, Dept of (DOS) 12 - White House Office 2 - HOUSE OF REPRESENTATIVES
INOVIO PHARMACEUTICALS, INC.
660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA, 19462, US
COOKAB HASHEMI COOKAB HASHEMI